Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

about

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

Item

http://www.wikidata.org/entity/Q49914014

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@en

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@nl

type

Item

label

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@en

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@nl

prefLabel

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@en

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@nl

P1476

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

@en

P2093

Lindsey R Sangaralingham

http://www.w3.org/2001/XMLSchema#string

Nilay D Shah

http://www.w3.org/2001/XMLSchema#string

S Jeson Sangaralingham

http://www.w3.org/2001/XMLSchema#string

Shannon M Dunlay

http://www.w3.org/2001/XMLSchema#string

Xiaoxi Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the epidemic of heart failure: past, present, and future

Angiotensin-neprilysin inhibition versus enalapril in heart failure

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure.

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Cost-effectiveness of implantable cardioverter-defibrillators.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o

P304

e004302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.117.004302

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29453287

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

5820776

http://www.w3.org/2001/XMLSchema#string